Your Health Today

Eli Lilly's Weight Loss Drug Shows 94% Reduction in Diabetes Risk in Major Study

Name: Eli Lilly's Weight Loss Drug Shows 94% Reduction in Diabetes Risk in Major Study
Uploaded: 2024-08-21T18:45:00-07:00
Channel: NBC Palm Springs
Description: Eli Lilly's weight loss drug, featuring the chemical Tirzepatide, has demonstrated a significant decrease in the risk of developing type 2 diabetes, according to the longest completed trial of the medication.

By: NBC Palm Springs

August 21, 2024

Eli LillyWeight Loss DrugDiabetes RiskTirzepatideClinical TrialType 2 DiabetesMonjaro

Link Copied To Clipboard!

More Headlines>>>